Adhera Therapeutics, Inc. (ATRX)

Market Cap	2.09M
Revenue (ttm)	132,000
Net Income (ttm)	-4.01M
Shares Out	11.67M
EPS (ttm)	-0.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	342,127
Open	0.1953
Previous Close	0.1400
Day's Range	0.1500 - 0.1953
52-Week Range	0.0340 - 0.2500
Beta	0.57
Analysts	n/a
Price Target	n/a
Est. Earnings Date	n/a

About ATRX

Adhera Therapeutics, Inc. does not have significant operations. Previously, it was involved in the development and commercialization of drug therapeutics for chronic and acute diseases in the United States. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

• Industry: Biotechnology
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: ATRX

Full Company Profile

Financial Performance

Financial Statements

News

Adhera Therapeutics Provides Insight on Corporate Strategy, Development of Parkinson's Disease and Type 1 Diabetes Drugs

Baton Rouge, LA, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, today provides shareholders an update...

1 week ago - GlobeNewsWire